Educational Grants

Unrestricted Educational Grants

Allergan recognizes the importance of independent medical education programs that enhance the level of patient care in the United States. As such, Allergan funds educational activities through its extensive unrestricted educational grant program to foster increased understanding of scientific, clinical, or health care issues. We seek to provide an efficient and effective grant review process to help facilitate grant requests for quality independent education.

Allergan operates under the highest ethical standards and in full compliance with all applicable laws, regulations, and guidelines. Approval of grant funding is never related to or conditioned upon past prescriptions or purchases of Allergan products. Furthermore, Allergan does not offer or provide educational grants to encourage or to reward the prescription, purchase, ordering, or recommending of Allergan products.

Our grant approval process is in accordance with the recommendations and the guidance of the Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers (PhRMA), the Accreditation Council for Continuing Medical Education Guidelines, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, as well as internal Allergan policies.

Begin the Allergan Medical Education grant process


Active Grants and/or pending requests:
All FRXIS stakeholders must complete the reconciliation process for active grants within FRXIS by January 1, 2018. Access to the FRXIS grant management system will not change and can be accessed via https://gms.frxis.com to complete the reconciliation or any other pending items, as well as check the status of your pending grant requests.


  • Cardiovascular Hypertension 
  • Chronic Migraine
  • Gastrointestinal Disease – Irritable Bowel Syndrome (with diarrhea or with constipation)
  • Infectious Disease – Bacterial Resistance
  • Medical Aesthetics
  • Neurology - Spasticity & Movement Disorders
  • Ophthalmology – Chronic Dry Eye, Glaucoma, Retinal Disease
  • Urology – Overactive Bladder
Allergan – Request for Proposals Notification

RFP Issue Date: September 09, 2016
Therapeutic Area: Alzheimer’s Disease
Request for Proposal: Online Activities
Deadline for Submission of Application: October 21, 2016